Incoming influenza a virus evades early host recognition, while influenza b virus induces interferon expression directly upon entry

Journal of Virology

Volumn 86, Issue 20, 2012, Pages 11183-11193

  Österlund, Pamela ^a   Strengell, Mari ^a   Sarin, L Peter ^b,c,d   Poranen, Minna M ^b   Fagerlund, Riku ^a,e   Melén, Krister ^a   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; NONSTRUCTURAL PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; CYTOSOL; DENDRITIC CELL; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RNA SYNTHESIS; ULTRAVIOLET RADIATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

ANIMALS; CELL LINE; DENDRITIC CELLS; DOGS; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INTERFERON REGULATORY FACTOR-3; INTERFERONS; MADIN DARBY CANINE KIDNEY CELLS; RNA, VIRAL; VIRUS INTERNALIZATION;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE;

EID: 84869034587     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01050-12     Document Type: Article

References (43)

1. Baum A, Sachidanandam R, Garcia-Sastre A. 2010. Preference of RIG-I for short viralRNAmolecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U. S. A. 107:16303-16308.
2. Betakova T, Nermut MV, Hay AJ. 1996. The NB protein is an integral component of the membrane of influenza B virus. J. Gen. Virol. 77(Pt 11):2689-2694.
3. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. 2007. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3:1414-1421. doi:10.1371/journal.ppat.0030141.
4. Crow M, Deng T, Addley M, Brownlee GG. 2004. Mutational analysis of the influenza virus cRNA promoter and identification of nucleotides critical for replication. J. Virol. 78:6263-6270.
5. Dauber B, et al. 2009. Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog. 5:e1000473. doi: 10.1371/journal.ppat.1000473.
6. Dauber B, Schneider J, Wolff T. 2006. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J. Virol. 80:11667-11677.
7. de Vries E, et al. 2011. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7:e1001329. doi:10.1371/journal.ppat.1001329.
8. DuBois RM, et al. 2011. Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathog. 7:e1002398. doi:10.1371/journal.ppat.1002398.
9. Gack MU, et al. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449.
10. Hai R, et al. 2008. Influenza B virus NS1-truncated mutants: liveattenuated vaccine approach. J. Virol. 82:10580-10590.
11. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-2376.
12. Hiscott J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483-490.
13. Ichinohe T, Pang IK, Iwasaki A. 2010. Influenza virus activates inflammasomes via its intracellularM2ion channel. Nat. Immunol. 11:404-410.
14. Jagger BW, et al. 28 June 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science doi: 10.1126/science.1222213.
15. Jiang M, et al. 2011. Innate immune responses in human monocytederived dendritic cells are highly dependent on the size and the 5' phosphorylation of RNA molecules. J. Immunol. 187:1713-1721.
16. Kato H, et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205:1601-1610.
17. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
18. Kim MJ, Latham AG, Krug RM. 2002. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc. Natl. Acad. Sci. U. S. A. 99:10096-10101.
19. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. 2003. Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 100:9280-9285.
20. Lakadamyali M, Rust MJ, Zhuang X. 2004. Endocytosis of influenza viruses. Microbes Infect. 6:929-936.
21. Loo YM, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-345.
22. Melen K, et al. 2007. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J. Virol. 81:5995-6006.
23. Min JY, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2'-5' oligo(A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U. S. A. 103: 7100-7105.
24. Min JY, Li S, Sen GC, Krug RM. 2007. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363:236-243.
25. Neumann G, et al. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U. S. A. 96:9345-9350.
26. Nicholson KG, Wood JM, Zambon M. 2003. Influenza. Lancet 362: 1733-1745.
27. Nobusawa E, Sato K. 2006. Comparison of the mutation rates of human influenza A and B viruses. J. Virol. 80:3675-3678.
28. Noda T, Kawaoka Y. 2010. Structure of influenza virus ribonucleoprotein complexes and their packaging into virions. Rev. Med. Virol. 20:380-391.
29. Osterlund P, et al. 2005. Gene expression and antiviral activity of alpha/ beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol. 79:9608-9617.
30. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. Immunol. 179:3434-3442.
31. Pachler K, Vlasak R. 2011. Influenza C virus NS1 protein counteracts RIG-I-mediated IFN signalling. Virol. J. 8:48. doi:10.1186/1743-422X-8-48.
32. Pichlmair A, et al. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001.
33. Pichlmair A, et al. 2009. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83:10761-10769.
34. Rehwinkel J, et al. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140:397-408.
35. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
36. Samuel CE. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
37. Sieczkarski SB, Whittaker GR. 2003. Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4:333-343.
38. Talon J, et al. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74:7989-7996.
39. tenOever BR, Servant MJ, Grandvaux N, Lin R, Hiscott J. 2002. Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J. Virol. 76:3659-3669.
40. tenOever BR, et al. 2004. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 78: 10636-10649.
41. Wang W, Krug RM. 1996. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223:41-50.
42. Wise HM, et al. 2009. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83:8021-8031.
43. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20:4-22.